Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment

[1]  Li-Jun Jiang,et al.  Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study. , 2021, The lancet. Psychiatry.

[2]  M. Baumgartner,et al.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision , 2021, Journal of inherited metabolic disease.

[3]  Wei Zhang,et al.  Peripheral Nervous System Involvement in Late-Onset Cobalamin C Disease? , 2020, Frontiers in Neurology.

[4]  Nan Li,et al.  Adolescent/adult-onset homocysteine remethylation disorders characterized by gait disturbance with/without psychiatric symptoms and cognitive decline: a series of seven cases , 2020, Neurological Sciences.

[5]  Zhehui Chen,et al.  Analysis of 70 patients with hydrocephalus due to cobalamin C deficiency , 2020, Neurology.

[6]  Yaping Tian,et al.  Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases , 2020, Orphanet Journal of Rare Diseases.

[7]  Ying-kun Guo,et al.  Pulmonary hypertension in late-onset Methylmalonic Aciduria and Homocystinemia: a case report , 2020, BMC Pediatrics.

[8]  C. Venditti,et al.  High‐dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency , 2019, JIMD reports.

[9]  X. Ji,et al.  Prenatal diagnosis of methylmalonic aciduria from amniotic fluid using genetic and biochemical approaches , 2019, Prenatal diagnosis.

[10]  Dong Li,et al.  Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review. , 2019, European journal of medical genetics.

[11]  L. Cui,et al.  Treatable cause of hereditary spastic paraplegia: eight cases of combined homocysteinaemia with methylmalonic aciduria , 2019, Journal of Neurology.

[12]  Yuying Zhao,et al.  Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series , 2019, Neuropsychiatric disease and treatment.

[13]  Yuying Zhao,et al.  Reversible encephalopathy caused by an inborn error of cobalamin metabolism , 2019, The Lancet.

[14]  X. Kong,et al.  Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria , 2018, BMC Medical Genetics.

[15]  V. Jakovljevic,et al.  Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems. , 2018, Canadian journal of physiology and pharmacology.

[16]  D. Cassiman,et al.  Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy , 2018, Kidney international reports.

[17]  Zhaoxia Wang,et al.  [Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China]. , 2018, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[18]  Dong Hwan Lee,et al.  Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening , 2018, Molecular genetics and metabolism reports.

[19]  W. Chung,et al.  A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients , 2018, Nature Communications.

[20]  P. Kaplan,et al.  Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: a 16-year experience , 2017, Genetics in Medicine.

[21]  M. Baumgartner,et al.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.

[22]  A. Diepstra,et al.  Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity , 2016, Pediatric Nephrology.

[23]  Liping Tian,et al.  Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China , 2016, Brain and Development.

[24]  Yanling Yang,et al.  First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type , 2015, Brain and Development.

[25]  Eda Özaydın,et al.  Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene , 2014, European Journal of Pediatrics.

[26]  R. Chandler,et al.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management , 2012, Journal of Inherited Metabolic Disease.

[27]  K. Hsiao,et al.  Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.

[28]  M. Baumgartner,et al.  Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.

[29]  C. Morel,et al.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.

[30]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[32]  S. Yamaguchi,et al.  Simplified screening for organic acidemia using GC/MS and dried urine filter paper: a study on neonatal mass screening. , 2000, Early human development.

[33]  木村 正彦,et al.  Automated metabolic profiling and interpretation of GC/MS data for organic acidemia screening : a personal computer-based system , 2000 .

[34]  S. Yamaguchi,et al.  Automated metabolic profiling and interpretation of GC/MS data for organic acidemia screening: a personal computer-based system. , 1999, The Tohoku journal of experimental medicine.